These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9294620)

  • 1. Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk.
    Devgan SA; Henderson BE; Yu MC; Shi CY; Pike MC; Ross RK; Reichardt JK
    Prostate; 1997 Sep; 33(1):9-12. PubMed ID: 9294620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.
    Neslund-Dudas C; Bock CH; Monaghan K; Nock NL; Yang JJ; Rundle A; Tang D; Rybicki BA
    Prostate; 2007 Nov; 67(15):1654-63. PubMed ID: 17823934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.
    Reichardt JK; Makridakis N; Henderson BE; Yu MC; Pike MC; Ross RK
    Cancer Res; 1995 Sep; 55(18):3973-5. PubMed ID: 7664265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GEN GEN: the genomic genetic analysis of androgen-metabolic genes and prostate cancer as a paradigm for the dissection of complex phenotypes.
    Reichardt JK
    Front Biosci; 1999 Jul; 4():D596-600. PubMed ID: 10417059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).
    Lunn RM; Bell DA; Mohler JL; Taylor JA
    Carcinogenesis; 1999 Sep; 20(9):1727-31. PubMed ID: 10469617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.
    Kantoff PW; Febbo PG; Giovannucci E; Krithivas K; Dahl DM; Chang G; Hennekens CH; Brown M; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):189-92. PubMed ID: 9138662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls.
    Marui S; Castro M; Latronico AC; Elias LL; Arnhold IJ; Moreira AC; Mendonca BB
    Clin Endocrinol (Oxf); 2000 Jan; 52(1):67-75. PubMed ID: 10651755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to find exon 7 polymorphism of the ADH7 gene in Chinese, Japanese, African-Americans, and Caucasians.
    Carr LG; Zeng D; Li TK
    Alcohol Clin Exp Res; 1996 May; 20(3):418-9. PubMed ID: 8727230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic steroid 5 alpha-reductase, an androgen metabolic gene.
    Reichardt JK
    Mayo Clin Proc; 2000 Jan; 75 Suppl():S36-9. PubMed ID: 10959214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.
    Platz EA; Pollak MN; Rimm EB; Majeed N; Tao Y; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1107-10. PubMed ID: 10613344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants.
    Tanus-Santos JE; Desai M; Flockhart DA
    Pharmacogenetics; 2001 Nov; 11(8):719-25. PubMed ID: 11692081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics.
    Wang L; Salavaggione E; Pelleymounter L; Eckloff B; Wieben E; Weinshilboum R
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):88-99. PubMed ID: 17689071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls.
    Tang YM; Green BL; Chen GF; Thompson PA; Lang NP; Shinde A; Lin DX; Tan W; Lyn-Cook BD; Hammons GJ; Kadlubar FF
    Pharmacogenetics; 2000 Dec; 10(9):761-6. PubMed ID: 11221602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects.
    Carlini EJ; Raftogianis RB; Wood TC; Jin F; Zheng W; Rebbeck TR; Weinshilboum RM
    Pharmacogenetics; 2001 Feb; 11(1):57-68. PubMed ID: 11207031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online.
    Walker AH; Jaffe JM; Gunasegaram S; Cummings SA; Huang CS; Chern HD; Olopade OI; Weber BL; Rebbeck TR
    Hum Mutat; 1998; 12(4):289. PubMed ID: 10660343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-ethnic group comparisons of HLA class II alleles and insulin dependent diabetes mellitus.
    Serjeantson SW; Easteal S
    Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):299-320. PubMed ID: 1892468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
    PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4.
    Zeigler-Johnson CM; Walker AH; Mancke B; Spangler E; Jalloh M; McBride S; Deitz A; Malkowicz SB; Ofori-Adjei D; Gueye SM; Rebbeck TR
    Hum Hered; 2002; 54(1):13-21. PubMed ID: 12446983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
    Bennett CL; Price DK; Kim S; Liu D; Jovanovic BD; Nathan D; Johnson ME; Montgomery JS; Cude K; Brockbank JC; Sartor O; Figg WD
    J Clin Oncol; 2002 Sep; 20(17):3599-604. PubMed ID: 12202660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic variation and in vivo effects of the -93t-->g promoter variant in the lipoprotein lipase gene.
    Ehrenborg E; Clee SM; Pimstone SN; Reymer PW; Benlian P; Hoogendijk CF; Davis HJ; Bissada N; Miao L; Gagné SE; Greenberg LJ; Henry R; Henderson H; Ordovas JM; Schaefer EJ; Kastelein JJ; Kotze MJ; Hayden MR
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2672-8. PubMed ID: 9409241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.